Overview on telmisartan therapy

Feryal Hashim Rada
{"title":"Overview on telmisartan therapy","authors":"Feryal Hashim Rada","doi":"10.30574/gscbps.2024.26.1.0498","DOIUrl":null,"url":null,"abstract":"Telmisartan is an antihypertensive drug belong to angiotensin II type 1 receptor blockers class. This review is focuses on pharmacokinetic and pharmacological effect of Telmisartan. Many scientific and important sites in the internet such as Scopus, Clarivate, Pubmed and others are used to collect publicized data and information to assess and organize this review. Moreover, Old articles and articles with abstract only were excluded. Telmisartan act by a manner differing from that of angiotensin-converting enzyme inhibitors. In addition to lowering blood pressure, Telmisartan has pleotropic effects on attenuation of many features such as inflammatory reactions, hypertrophy of left ventricle, and fibrillation of atrium. As well, amelioration of vascular activity, and renal functions will obtain. Telmisartan has many features that differentiate it from other drugs of angiotensin II type 1 receptor blockers and give its specific effect such as high lipophilic characters, extended half-life in plasma, and high affinity of binding with its receptor.","PeriodicalId":12808,"journal":{"name":"GSC Biological and Pharmaceutical Sciences","volume":"2 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"GSC Biological and Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30574/gscbps.2024.26.1.0498","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Telmisartan is an antihypertensive drug belong to angiotensin II type 1 receptor blockers class. This review is focuses on pharmacokinetic and pharmacological effect of Telmisartan. Many scientific and important sites in the internet such as Scopus, Clarivate, Pubmed and others are used to collect publicized data and information to assess and organize this review. Moreover, Old articles and articles with abstract only were excluded. Telmisartan act by a manner differing from that of angiotensin-converting enzyme inhibitors. In addition to lowering blood pressure, Telmisartan has pleotropic effects on attenuation of many features such as inflammatory reactions, hypertrophy of left ventricle, and fibrillation of atrium. As well, amelioration of vascular activity, and renal functions will obtain. Telmisartan has many features that differentiate it from other drugs of angiotensin II type 1 receptor blockers and give its specific effect such as high lipophilic characters, extended half-life in plasma, and high affinity of binding with its receptor.
替米沙坦治疗概述
替米沙坦是一种抗高血压药物,属于血管紧张素 II 1 型受体阻滞剂。本综述的重点是替米沙坦的药代动力学和药理作用。为了评估和组织这篇综述,我们使用了许多重要的科学网站,如 Scopus、Clarivate、Pubmed 等,以收集公开的数据和信息。此外,还排除了旧文章和只有摘要的文章。替米沙坦的作用方式与血管紧张素转换酶抑制剂不同。除了降低血压外,替米沙坦还具有减轻炎症反应、左心室肥大和心房颤动等多种特征的多方面作用。此外,还能改善血管活动和肾功能。替米沙坦有许多不同于其他血管紧张素 II 1 型受体阻滞剂的特点,并赋予其特殊的效果,如高亲脂性、在血浆中的半衰期延长、与受体结合的亲和力强等。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信